A narrative review of influenza: A seasonal and pandemic disease

Iranian Journal of Medical Sciences

Volumn 42, Issue 1, 2017, Pages 2-13

  Moghadami, Mohsen ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human; Influenza; Respiratory system; Vaccination

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ACUTE LIVER FAILURE; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; CLINICAL DECISION MAKING; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MOLECULAR DIAGNOSIS; MORBIDITY; MORTALITY; MYOCARDITIS; MYOGLOBINURIA; MYOSITIS; NONHUMAN; ORTHOMYXOVIRIDAE; PANDEMIC INFLUENZA; PATHOPHYSIOLOGY; PERICARDITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIMARY INFLUENZA VIRAL PNEUMONIA; RAPID INFLUENZA DIAGNOSTIC TEST; RAPID TEST; REVIEW; REYE SYNDROME; RHABDOMYOLYSIS; RISK ASSESSMENT; SEASONAL INFLUENZA; SYMPTOMATOLOGY; VACCINATION; VIRUS TRANSMISSION;

EID: 85012110631     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Shrestha S, Foxman B, Berus J, van Panhuis WG, Steiner C, Viboud C, et al. The role of influenza in the epidemiology of pneumonia. Sci Rep. 2015;5:15314. doi: 10.1038/srep15314.
2. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347:aaa4339. doi: 10.1126/science.aaa4339.
3. Hirsch A. Handbook of geographical and historical pathology. London: New Sydenham Society; 1883.
4. Molineux D. Dr. Molineux's Historical Account of the Late General Coughs and Colds; with Some Observations on Other Epidemick Distempers. Philosophical Transactions (1683-1775). 1694:105-11.
5. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002;76:105-15.
6. Novel Swine-Origin Influenza AVIT, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15. doi: 10.1056/NEJMoa0903810.
7. Influenza WP. Report of the WHO pandemic influenza A (H1N1) vaccine deployment initiative. 2012.
8. Mosnier A, Caini S, Daviaud I, Nauleau E, Bui TT, Debost E, et al. Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections. PLoS One. 2015;10:e0136186. doi: 10.1371/journal.pone.0136186.
9. Poon LL, Song T, Rosenfeld R, Lin X, Rogers MB, Zhou B, et al. Quantifying influenza virus diversity and transmission in humans. Nat Genet. 2016;48:195-200. doi: 10.1038/ng.3479.
10. Fuller TL, Gilbert M, Martin V, Cappelle J, Hosseini P, Njabo KY, et al. Predicting hotspots for influenza virus reassortment. Emerg Infect Dis. 2013;19:581-8. doi: 10.3201/eid1904.120903.
11. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, et al. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J Virol. 1990;64:2860-5.
12. Moghadami M, Moattari A, Tabatabaee HR, Mirahmadizadeh A, Rezaianzadeh A, Hasanzadeh J, et al. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran. Iran J Immunol. 2010;7:39-48. doi: IJIv7i1A5.
13. Webster RG, Kendal AP, Gerhard W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology. 1979;96:258-64.
14. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517-25. doi: 10.1001/jama.2010.479.
15. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172-5.
16. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-67. doi: 10.1056/NEJMoa051721.
17. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis. 2007;7:257-65. doi: 10.1016/S1473-3099(07)70029-4.
18. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-24.
19. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4:1935. doi: 10.1038/ncomms2922.
20. Wong BC, Lee N, Li Y, Chan PK, Qiu H, Luo Z, et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis. 2010;51:1176-83. doi: 10.1086/656743.
21. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-85. doi: 10.1093/aje/kwm375.
22. Boivin G, Goyette N, Bernatchez H. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Clin Infect Dis. 2002;34:E23-5. doi: 10.1086/338870.
23. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med. 2003;348:867-8. doi: 10.1056/NEJM200302273480923.
24. Liu W, Peng L, Liu H, Hua S. Pulmonary Function and Clinical Manifestations of Patients Infected with Mild Influenza A Virus Subtype H1N1: A One-Year Follow-Up. PLoS One. 2015;10:e0133698. doi: 10.1371/journal.pone.0133698.
25. Rello J, Pop-Vicas A. Clinical review: primary influenza viral pneumonia. Crit Care. 2009;13:235. doi: 10.1186/cc8183.
26. Minodier L, Charrel RN, Ceccaldi PE, van der Werf S, Blanchon T, Hanslik T, et al. Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know? Virol J. 2015;12:215. doi: 10.1186/s12985-015-0448-4.
27. Kloth C, Forler S, Gatidis S, Beck R, Spira D, Nikolaou K, et al. Comparison of chest-CT findings of Influenza virus-associated pneumonia in immunocompetent vs. immunocompromised patients. Eur J Radiol. 2015;84:1177-83. doi: 10.1016/j. ejrad.2015.02.014.
28. Mancinelli L, Onori M, Concato C, Sorge R, Chiavelli S, Coltella L, et al. Clinical features of children hospitalized with influenza A and B infections during the 2012-2013 influenza season in Italy. BMC Infect Dis. 2016;16:6. doi: 10.1186/s12879-015-1333-x.
29. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148. doi: 10.1186/cc8044.
30. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50:850-9. doi: 10.1086/650581.
31. Schwarzmann SW, Adler JL, Sullivan RJ, Jr., Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med. 1971;127:1037-41.
32. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53:358-65. doi: 10.1016/j.annemergmed.2008.04.027.
33. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis. 2005;40:415-22. doi: 10.1086/427282.
34. Foulkes W, Rees J, Sewry C. Influenza A and rhabdomyolysis. J Infect. 1990;21:303-4.
35. Chen KF, Gaydos C, Rothman RE. Update on emerging infections: news from the Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection--California, April-May, 2009. Ann Emerg Med. 2009;54:732-6.
36. Kaufman MA, Duke GJ, McGain F, French C, Aboltins C, Lane G, et al. Life-threatening respiratory failure from H1N1 influenza 09 (human swine influenza). Med J Aust. 2009;191:154-6.
37. Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR. Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza Other Respir Viruses. 2012;6:80-6. doi: 10.1111/j.1750-2659.2011.00284.x.
38. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156:500-11. doi: 10.7326/0003-4819-156-7-201204030-00403.
39. Lee BY, McGlone SM, Bailey RR, Wiringa AE, Zimmer SM, Smith KJ, et al. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS One. 2010;5:e11284. doi: 10.1371/journal.pone.0011284.
40. Nagase H, Moriwaki K, Kamae M, Yanagisawa S, Kamae I. Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan. Value Health. 2009;12 Suppl 3:S62-5. doi: 10.1111/j.1524-4733.2009.00629.x.
41. Nshimyumukiza L, Douville X, Fournier D, Duplantie J, Daher RK, Charlebois I, et al. Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment. Influenza Other Respir Viruses. 2016;10:113-21. doi: 10.1111/irv.12359.
42. Kumar S, Henrickson KJ. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev. 2012;25:344-61. doi: 10.1128/CMR.05016-11.
43. Teo J, Di Pietro P, San Biagio F, Capozzoli M, Deng YM, Barr I, et al. VereFlu: an integrated multiplex RT-PCR and microarray assay for rapid detection and identification of human influenza A and B viruses using lab-on-chip technology. Arch Virol. 2011;156:1371-8. doi: 10.1007/s00705-011-0999-7.
44. Tang YW, Lowery KS, Valsamakis A, Schaefer VC, Chappell JD, White-Abell J, et al. Clinical accuracy of a PLEX-ID flu device for simultaneous detection and identification of influenza viruses A and B. J Clin Microbiol. 2013;51:40-5. doi: 10.1128/JCM.01978-12.
45. Loeffelholz MJ, Pong DL, Pyles RB, Xiong Y, Miller AL, Bufton KK, et al. Comparison of the FilmArray Respiratory Panel and Prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol. 2011;49:4083-8. doi: 10.1128/JCM.05010-11.
46. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003-32. doi: 10.1086/598513.
47. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395-404. doi: 10.1016/S2213-2600(14)70041-4.
48. Gasparini R, Amicizia D, Lai PL, Bragazzi NL, Panatto D. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg. 2014;55:69-85.
49. World Health Organization (WHO) [Internet]. Clinical management of human infection with pandemic (H1N1) 2009: Revised guidance. [cited 2014 November 18]. Available from: http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf
50. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667-72. doi: 10.1001/archinte.163.14.1667.
51. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156:512-24. doi: 10.7326/0003-4819-156-7-201204030-00411.
52. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: recommendations from the Tamiflu experience. PLoS Med. 2012;9:e1001201. doi: 10.1371/journal.pmed.1001201.
53. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses. 2016;10:192-204. doi: 10.1111/irv.12363.
54. Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, et al. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis. 2011;203:838-46. doi: 10.1093/infdis/jiq124.
55. Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis. 2009;48:389-96. doi: 10.1086/596311.
56. Ramos EL, Mitcham JL, Koller TD, Bonavia A, Usner DW, Balaratnam G, et al. Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza. J Infect Dis. 2015;211:1038-44. doi: 10.1093/infdis/jiu539.
57. Schotsaert M, De Filette M, Fiers W, Saelens X. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines. 2009;8:499-508. doi: 10.1586/erv.09.6.
58. Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol. 2004;172:5598-605.
59. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211:80-90. doi: 10.1093/infdis/jiu396.
60. Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, Socias L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect. 2012;64:311-8. doi: 10.1016/j.jinf.2011.12.010.
61. Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L, Group R-SAHNvR. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011;183:1200-6. doi: 10.1164/rccm.201101-0135OC.
62. Linko R, Pettila V, Ruokonen E, Varpula T, Karlsson S, Tenhunen J, et al. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland. Acta Anaesthesiol Scand. 2011;55:971-9. doi: 10.1111/j.1399-6576.2011.02491.x.
63. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS. Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. J Infect Dis. 2015;212:183-94. doi: 10.1093/infdis/jiu645.
64. Kilbourne ED. Influenza immunity: new insights from old studies. J Infect Dis. 2006;193:7-8. doi: 10.1086/498984.
65. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N Engl J Med. 2008;359:2579-85. doi: 10.1056/NEJMcp0807498.
66. Ang LW, Tien WS, Lin RT, Cui L, Cutter J, James L, et al. Characterization of influenza activity based on virological surveillance of influenza-like illness in tropical Singapore, 2010-2014. J Med Virol. 2016;88:2069-77. doi: 10.1002/jmv.24566.
67. Zhao B, Qin S, Teng Z, Chen J, Yu X, Gao Y, et al. Epidemiological study of influenza B in Shanghai during the 2009-2014 seasons: implications for influenza vaccination strategy. Clin Microbiol Infect. 2015;21:694-700. doi: 10.1016/j.cmi.2015.03.009.
68. Meerhoff TJ, Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, et al. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases. BMC Infect Dis. 2015;15:1. doi: 10.1186/s12879-014-0722-x.
69. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep. 2015;64:818-25.
70. Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2015;211:1519-28. doi: 10.1093/infdis/jiu650.
71. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015;64:10-5.
72. Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, et al. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014. Vaccine. 2015;33:4368-82. doi: 10.1016/j.vaccine.2015.06.090.
73. Li TC, Chan MC, Lee N. Clinical Implications of Antiviral Resistance in Influenza. Viruses. 2015;7:4929-44. doi: 10.3390/v7092850.
74. Merritt T, Hope K, Butler M, Durrheim D, Gupta L, Najjar Z, et al. Effect of antiviral prophylaxis on influenza outbreaks in aged care facilities in three local health districts in New South Wales, Australia, 2014. Western Pac Surveill Response J. 2016;7:14-20. doi: 10.5365/WPSAR.2015.6.3.005.
75. Louie JK, Salibay CJ, Kang M, Glenn-Finer RE, Murray EL, Jamieson DJ. Pregnancy and severe influenza infection in the 2013-2014 influenza season. Obstet Gynecol. 2015;125:184-92. doi: 10.1097/AOG.0000000000000593.